TherapeuticsMD (TXMD) Misses Q1 EPS by 1c

TherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($0.11), $0.01 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $4.19 million.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• EquipmentShare raises 2026 outlook, approves $500M buyback
• Hongli Group receives Nasdaq minimum bid price deficiency notice